PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript

Understand this faster with AI
SA Transcripts159.13K FollowersFollow5ShareSaveComments PAVmed Inc. (PAVM) Shareholder/Analyst Call March 27, 2026 10:00 AM EDT Company Participants Lishan Aklog - Chairman & CEOMichael Gordon - Executive VP, General Counsel & Secretary Conference Call Participants Eric SchwartzAlwyn Burton Presentation Lishan AklogChairman & CEO I call the Special Meeting of Stockholders of PAVmed Inc. to order. I am Lishan Aklog, the company's Chairman and Chief Executive Officer. Also present are Dennis McGrath, the company's President and Chief Financial Officer; Michael Gordon, the company's General Counsel; Eric Schwartz of Graubard Miller, outside Counsel of the company; and Alwyn Burton of Continental Stock Transfer & Trust Company, the company's transfer agent. Eric will act as the Secretary of the meeting. As you all know, we're holding this special meeting via live webcast. To help the meeting run smoothly, Mr. Gordon will review a couple of housekeeping items before we begin. Michael GordonExecutive VP, General Counsel & Secretary Thanks, Lishan. First, until the polls are closed towards the end of the meeting, you will have an opportunity to vote through the webcast platform. If you wish to vote, simply click on the voting link and follow the instructions. Voting through the webcast platform will revoke any previously delivered proxy. Second, during the meeting, you will have the opportunity to submit questions to management. You may submit questions through the questions pane in the webcast platform. We will review these questions and if appropriate, we'll respond to them after the meeting. Third, during the meeting, you may view a list of stockholders of record as of the close of business on the record date as certified by Continental Stock Transfer & Trust Company. Simply click on the corresponding link in the webcast platform. Lishan AklogChairman & CEO With those matters addressed, we will now proceed to the
Tags
Source Information
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
